Target intelligence / Profile preview

Calcium influx in smooth muscle cell

Molecular classification
Ion channel, Voltage-gated calcium channel (mainly L-type/Cav1.2), Receptor-operated channels, Store-operated calcium channels
01

Overview

Calcium influx in smooth muscle cells is a crucial physiological process mediated by several types of ion channels, most notably voltage-dependent L-type calcium channels (such as Cav1.2). This influx raises intracellular calcium concentrations, initiating contractile processes (excitation-contraction coupling), regulating cell elasticity and adhesion via effects on the actin cytoskeleton and integrin-mediated extracellular matrix interactions, and is fundamental to the maintenance of vascular tone. Dysregulation of calcium influx contributes to diseases including hypertension, atherosclerosis, and vascular calcification. Drugs that block L-type calcium channels are used therapeutically in cardiovascular disease to induce vasodilation and reduce blood pressure, but can have notable safety concerns due to their effects on other tissues.

Other names
Calcium signaling in smooth muscle cellSmooth muscle cell calcium entryVoltage-gated calcium channel (context-dependent)
02

Mechanism of action

Inhibition of voltage-dependent L-type calcium channels reduces calcium influx, resulting in smooth muscle relaxation and vasodilation. Blockade of receptor-operated calcium channels may reduce pathological or agonist-mediated contraction.

03

Biological functions

Contraction (excitation-contraction coupling)Signal transductionRegulation of vascular toneCell adhesion and cytoskeletal rearrangementRegulation of extracellular matrix interactions
04

Disease associations

Cardiovascular disease (hypertension, atherosclerosis)ArteriosclerosisVascular calcificationSmooth muscle hyperactivity disorders
05

Safety considerations

Excessive inhibition: hypotension, bradycardia, heart failure when L-type channels are blocked systemicallyNonspecificity leading to unwanted smooth muscle relaxation in gastrointestinal, uterine, or bronchial tissues
06

Interacting drugs

Calcium channel blockers (e.g., nifedipine, verapamil, diltiazem)

2 more in the full profile.

07

Biomarkers

Intracellular calcium levels (measured by fluorescent dyes)Expression of L-type calcium channel subunits (e.g., CACNA1C/Cav1.2)Downstream contractile proteins phosphorylated in response to calcium influx (e.g., myosin light chain phosphorylation)

Beyond the preview

Go deeper on Calcium influx in smooth muscle cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium influx in smooth muscle cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call